Home » Topics » BioWorld Science

BioWorld Science
RSS

PCYT2 as a novel disease gene for complex hereditary spastic paraplegia

Sep. 10, 2019

Preclinical characterization of novel mGlu2 receptor PAMs for the treatment of substance abuse

Sep. 10, 2019

Cassava Sciences announces phase IIa data for PTI-125 in Alzheimer's disease

Sep. 10, 2019

Results from phase II ADAMANT trial of AADvac-1 in Alzheimer's disease reported

Sep. 10, 2019

Lilly reports promising results from phase I/II study of selpercatinib in RET fusion-positive NSCLC

Sep. 10, 2019

Aptorum announces updates in preclinical pipeline

Sep. 10, 2019

Phospholipase D inhibitors developed for testing in neurodegeneration models

Sep. 10, 2019

Experimental model developed for PACAP-induced headache

Sep. 10, 2019

Cheerful gut bug has relationship with antidepressant

Sep. 10, 2019

Parasite protects T cells from HIV

Sep. 10, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...